Bordeaux, Boston, December 14, 2022 – 6:00 p.m. CET: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in spinal implants, today announces its financial agenda for 2023.
Events
2022 annual revenue: January 24, 2023
2022 annual results: March 7, 2023
Annual General Meeting: April 18, 2023
Q1 2023 revenue: April 25, 2023
First-half 2023 revenue: July 11, 2023
First-half 2023 results: September 19, 2023
Q3 2023 revenue: October 17, 2023
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected]